Black Bird Biotech, Inc. filed its 10-K on Mar 21, 2023 for the period ending Dec 31, 2022. In this report its auditor, Farmer, Fuqua & Huff, P.C. , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | -50.00% | 0.00% |
Apr. 16 | Black Bird Biotech, Inc. Appoints Nelson Grist as New CEO | CI |
Apr. 16 | Black Bird Biotech, Inc. Appoints Nelson Grist as Its Future Member of Its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 298K | |
+35.04% | 5.92B | |
-15.13% | 4.51B | |
-9.75% | 3.15B | |
+2.14% | 3.1B | |
-6.82% | 2.42B | |
+47.87% | 1.97B | |
-7.89% | 1.68B | |
+0.09% | 1.65B | |
-12.97% | 1.53B |
- Stock Market
- Equities
- BBBT Stock
- News Black Bird Biotech, Inc.
- Black Bird Biotech, Inc. Auditor Raises 'Going Concern' Doubt